Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)

Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, +15

Journal of Clinical Oncology

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy

Thomas Moehler, Kai Neben, Axel Benner, +4

Blood

EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

Stefano Ferrari, Stefan Bielack, Sigbjørn Smeland, +30

Tumori Journal

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Emanuele Zucca, Stéphanie Rondeau, Anna Vanazzi, +23

Blood

Pentostatin/Cyclophosphamide with or Without Rituximab: An Effective Regimen for Patients with Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Manfred Hensel, Matthias Villalobos, Martin Kornacker, +2

Clinical Lymphoma & Myeloma

Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyMacroglobulinemia/lymphoplasmacytic Lymphoma +4

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study

Ivar Hompland, Stefano Ferrari, Stefan Bielack, +31

European Journal of Cancer

Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study

Nina Anžič, Fatime Krasniqi, Anna-Lena Eberhardt, +2

Case Reports in Oncology

ImmunologyPathologyImmunotherapyTumor BiologyOncology +14

Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022

Christian Rothermundt, Dimosthenis Andreou, Jean‐Yves Blay, +82

European Journal of Cancer

Surgical OncologyOncologySoft Tissue SarcomaSurgical PathologyPathology +2

Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

Bernd Kasper, Christoph Harter, Frauke Bellos, +3

Supportive Care in Cancer

Metronomic TherapyHigh-dose IfosfamideProphylactic TreatmentIfosfamide-induced EncephalopathyPharmacotherapy +2

Rituximab Plus Lenalidomide Improves the Complete Remission Rate in Comparison with Rituximab Monotherapy in Untreated Follicular Lymphoma Patients in Need of Therapy. Primary Endpoint Analysis of the Randomized Phase-2 Trial SAKK 35/10

Eva Kimby, Giovanni Martinelli, Ulrich Mey, +21

Blood